ANXA2 and nasopharyngeal carcinoma: Meanwhile, a meta-analysis was collected from fifteen studies including 2,321 patients, 14 cancer types (not including NPC) demonstrated that the overexpression of ANXA2 was correlated with poor prognosis in term of overall survival, disease-free survival and significantly associated with tumor invasion and lymph mode metastasis [23].